The Food and Drug Administration (FDA) has given its green signal to Roche Molecular Systems’s alternative papilloma virus test to treat cervical cancer, in women aged 25 and older. The test, commonly known as the Cobas HPV test, is a DNA-based test for the virus that can cause cervical cancer. Such DNA-based tools are being used by the doctors as a follow-up to confirm Pap test results. But … [Read more...]
FDA gives nod to controversial Cobas HPV test
The Food and Drug Administration (FDA) has given its green signal to Roche Molecular Systems’s alternative papilloma virus test to treat cervical cancer. The test, commonly known as the Cobas HPV test, is a DNA-based test for the virus that can cause cervical cancer. The research and clinical trial for the newly FDA-approved Cobas HPV test was conducted in Pleasanton. After the FDA nod, the … [Read more...]